Unknown

Dataset Information

0

Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection.


ABSTRACT: BACKGROUND:Acute respiratory infections (ARI) are a leading cause of morbidity and mortality worldwide. There is a need to demonstrate the clinical impact of using the new, rapid and sensitive molecular assays in prospectively designed studies. OBJECTIVES:To study the impact on medical management of a rapid molecular assay in patients with respiratory infections. STUDY DESIGN:A prospective, randomized, non-blinded study was performed in patients presenting to the Emergency Department during two respiratory seasons (2016-2017). Diagnosis was performed by FilmArray Respiratory Panel (FilmArray-RP) or by immunofluorescence assay (IFA). RESULTS:A total of 432 patients (156 children and 276 adults) were analyzed. Diagnosis with FilmArray-RP was associated with significant changes in medical management including withholding antibiotic prescriptions (OR:15.52, 95%CI:1.99-120.83 in adults and OR:12.23, 95%CI:1.56-96.09 in children), and reduction in complementary studies in children (OR:9.64, 95%CI:2.13-43.63) compared to IFA. Decrease in oseltamivir prescriptions was significantly higher in adults in the FilmArray-RP group (p?=?0.042; OR:1.19, 95%CI:0.51-2.79) compared to adults managed with IFA. Diagnostic yield was significantly higher by FilmArray-RP (81%) than by IFA (31%)(p?

SUBMITTER: Echavarria M 

PROVIDER: S-EPMC7172208 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical impact of rapid molecular detection of respiratory pathogens in patients with acute respiratory infection.

Echavarría M M   Marcone D N DN   Querci M M   Seoane A A   Ypas M M   Videla C C   O'Farrell C C   Vidaurreta S S   Ekstrom J J   Carballal G G  

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20180914


<h4>Background</h4>Acute respiratory infections (ARI) are a leading cause of morbidity and mortality worldwide. There is a need to demonstrate the clinical impact of using the new, rapid and sensitive molecular assays in prospectively designed studies.<h4>Objectives</h4>To study the impact on medical management of a rapid molecular assay in patients with respiratory infections.<h4>Study design</h4>A prospective, randomized, non-blinded study was performed in patients presenting to the Emergency  ...[more]

Similar Datasets

| S-EPMC7829496 | biostudies-literature
| PRJEB39606 | ENA
| S-EPMC5317157 | biostudies-literature
| S-EPMC6424078 | biostudies-literature
| S-EPMC7094527 | biostudies-literature
| S-EPMC7040966 | biostudies-literature
| S-EPMC6617970 | biostudies-literature
| S-EPMC8376372 | biostudies-literature
| S-EPMC7108200 | biostudies-literature
| S-EPMC7106522 | biostudies-literature